Potential Involvement of BIRC5 in Maintaining Pluripotency and Cell Differentiation of Human Stem Cells.

作者: Paulina Gil-Kulik , Arkadiusz Krzyżanowski , Ewa Dudzińska , Jolanta Karwat , Piotr Chomik

DOI: 10.1155/2019/8727925

关键词: Mesenchymal stem cellStem cellCD34Cellular differentiationRegulation of gene expressionHaematopoiesisCell cultureCell biologySurvivinBiology

摘要: The BIRC5 gene encodes a survivin protein belonging to class III of inhibitors apoptosis, IAP. This serves dual role. First, it regulates cell death, and second, is an important regulator mitosis progression, although its physiological regulatory function has not been fully understood. Many studies have shown confirmed that practically absent in mature tissues nature, while overexpression reported many cancerous tissues. There little information about the significance expression normal adult human stem cells. paper presents study analysis at transcription level using qPCR method, hematopoietic cells from peripheral blood mobilized with granulocyte growth factor, adherent derived umbilical cord, bone marrow this was also examined healthy individuals. results more are, lower is. lowest found cells, highest CD34+ CD105 tested material higher Stem culture show expression. confirms involvement IAP family processes apart apoptosis inhibition. possible effect on proliferation; cycle, differentiation, survival, maintenance cells; antineoplastic properties mesenchymal demonstrated. Our research suggests may be responsible for condition pluripotency high dedifferentiation tumor

参考文章(56)
A O de Graaf, T de Witte, J H Jansen, Inhibitor of apoptosis proteins: new therapeutic targets in hematological cancer? Leukemia. ,vol. 18, pp. 1751- 1759 ,(2004) , 10.1038/SJ.LEU.2403493
Chui-Yee Fong, Li-Ling Chak, Arijit Biswas, Jee-Hian Tan, Kalamegam Gauthaman, Woon-Khiong Chan, Ariff Bongso, None, Human Wharton’s Jelly Stem Cells Have Unique Transcriptome Profiles Compared to Human Embryonic Stem Cells and Other Mesenchymal Stem Cells Stem Cell Reviews and Reports. ,vol. 7, pp. 1- 16 ,(2011) , 10.1007/S12015-010-9166-X
Anupam Kumar Srivastava, Pankaj Kumar Singh, Kirti Srivastava, Dhramveer Singh, Divakar Dalela, Srikanta Kumar Rath, Madhu Mati Goel, Madan Lal Brahma Bhatt, Diagnostic Role of Survivin in Urinary Bladder Cancer Asian Pacific Journal of Cancer Prevention. ,vol. 14, pp. 81- 85 ,(2013) , 10.7314/APJCP.2013.14.1.81
Casey W Wright, Colin S Duckett, Reawakening the cellular death program in neoplasia through the therapeutic blockade of IAP function Journal of Clinical Investigation. ,vol. 115, pp. 2673- 2678 ,(2005) , 10.1172/JCI26251
S Pervin, L Tran, R Urman, M Braga, M Parveen, S A Li, G Chaudhuri, R Singh, Oxidative stress specifically downregulates survivin to promote breast tumour formation British Journal of Cancer. ,vol. 108, pp. 848- 858 ,(2013) , 10.1038/BJC.2013.40
Thomas W Owens, Andrew P Gilmore, Charles H Streuli, Fiona M Foster, Inhibitor of Apoptosis Proteins: Promising Targets for Cancer Therapy. Journal of carcinogenesis & mutagenesis. ,vol. 2013, pp. 1- 9 ,(2013) , 10.4172/2157-2518.S14-004
Michaela R. Reagan, Clifford J. Rosen, Navigating the bone marrow niche: translational insights and cancer-driven dysfunction Nature Reviews Rheumatology. ,vol. 12, pp. 154- 168 ,(2016) , 10.1038/NRRHEUM.2015.160
Xun Chen, Ning Duan, Caiguo Zhang, Wentao Zhang, Survivin and Tumorigenesis: Molecular Mechanisms and Therapeutic Strategies Journal of Cancer. ,vol. 7, pp. 314- 323 ,(2016) , 10.7150/JCA.13332
John Silke, Domagoj Vucic, IAP family of cell death and signaling regulators. Methods in Enzymology. ,vol. 545, pp. 35- 65 ,(2014) , 10.1016/B978-0-12-801430-1.00002-0
Shixin Zhou, Yinan Liu, Ruopeng Feng, Caiyun Wang, Sibo Jiang, Xiaoyan Zhang, Feng Lan, Yang Li, Survivin Improves Reprogramming Efficiency of Human Neural Progenitors by Single Molecule OCT4. Stem Cells International. ,vol. 2016, pp. 4729535- 4729535 ,(2016) , 10.1155/2016/4729535